Table 2.
Area of care | Process of care Indicator* | Eligible patients** | Description |
---|---|---|---|
Dyslipidemia | Lipid profile | All patients | Method of measuring blood cholesterol levels |
Lipid lowering drug | Dyslipidemia | Prescribed to reduce levels of LDL cholesterol ('bad' cholesterol) | |
Diabetes | 2 Hemoglobin A1c (HbA1c) tests | Diabetes | Measures average blood sugar level over past 3-4 months |
Chronic kidney disease | Estimated glomerular filtration rate (eGFR) | Chronic kidney disease | Used to assess kidney function |
Hypertension | 2 blood pressure measures | Hypertension | Hypertension is a risk factor for heart disease & stroke |
Anti-hypertensive drug | Taken to reduce blood pressure i.e. ACE Inhibitors, Beta Blockers | ||
Weight | Waist circumference measure | All patients | Waistline is a strong predictor of cardiovascular disease-related risk factors, all cause mortality, and Type II diabetes |
Smoking cessation advice | |||
Smoking cessation | Smoking cessation program referral | Smokers | Physician advice and cessation programs strongly impact patient smoking status |
Smoking cessation drug therapy | i.e. Nicotine replacement therapies |
*Was the following process of care indicator discussed/recommended/performed during the past 12 months for this patient ** The eligibility for recommended processes of care varies for each patient depending on current diagnoses. For example, monitoring HbA1c twice within a year is only recommended for patients with diabetes.